Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$453,186
-$131,279 QoQ
Shares Held
100,708
+6.0% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $125,736,773 across 21 Diagnostics & Research names. MYGN ranks #17 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
178,851 | $22,045,174 | |
| 2 | QGEN |
Qiagen N.V.
|
493,645 | $19,765,545 | |
| 3 | A |
Agilent Technologies, Inc.
|
132,823 | $15,139,165 | |
| 4 | TWST |
Twist Bioscience Corp
|
258,604 | $12,288,862 | |
| 5 | WAT |
Waters Corp /De/
|
32,254 | $9,605,241 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
52,959 | $9,135,427 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
15,003 | $8,430,035 | |
| 8 | DHR |
Danaher Corp /De/
|
40,074 | $7,598,030 |
All Filings in MYGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $453,186 | 100,708 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $584,465 | 95,035 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $400,896 | 55,449 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $178,495 | 33,615 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $261,398 | 29,470 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $451,333 | 32,920 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $505,208 | 18,445 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $803,975 | 32,869 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||